FIELD: pharmacology.
SUBSTANCE: group of inventions refers to using tridecapeptide H-Tyr-D-Arg-Phe-Gly-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-Gly-OH·10HCl as an analgesic agent, as well as to a dosage form containing tridecapeptide H-Tyr-D-Arg-Phe-Gly-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-Gly-OH·10HCl.
EFFECT: group of inventions is effective in managing acute pain syndrome in extreme medicine and therapy of chronic pain syndrome, particularly at late stages of oncologic diseases.
3 cl, 3 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANALGESIC AGENT OF PEPTIDE STRUCTURE OF UNDERCAPEPTIDE CONTAINING D-OCTAARGININE VECTOR | 2013 |
|
RU2541127C1 |
| PEPTIDE FOR MEDICAL TREATMENT OF PANCREATIC DIABETES OF 2ND TYPE AND ITS COMPLICATIONS | 2014 |
|
RU2573933C1 |
| METHOD FOR PRODUCING PEPTIDE EXENATIDE | 2011 |
|
RU2458066C1 |
| METHOD OF IMMUNE-ENZYME ASSAY FOR DETECTING β-ADRENORECEPTOR AUTOIMMUNE ANTIBODIES IN HUMAN BLOOD PLASMA AND SERUM | 2011 |
|
RU2452964C1 |
| SYNTHETIC ANTIGEN ABILITY TO BIND β-ADRENORECEPTOR AUTOANTIBODIES | 2007 |
|
RU2356576C1 |
| COMPOSITION AND METHOD FOR PRODUCING PEPTIDE ANALGETIC AGENT | 2017 |
|
RU2669386C1 |
| HYPOGLYCEMIC AGENT OF PEPTIDE STRUCTURE INHIBITING DIPEPTIDYL PEPTIDASE-4 | 2015 |
|
RU2600810C1 |
| FAMILY OF PEPTIDES POSSESSING ANALGESIC ACTIVITY | 2005 |
|
RU2286169C1 |
| AGENT OF PEPTIDE STRUCTURE, INHIBITING DIPEPTIDYL PEPTIDASE-4, AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2015 |
|
RU2589258C1 |
| MASP INHIBITING COMPOUNDS AND APPLICATIONS THEREOF | 2020 |
|
RU2840441C2 |
